Which has the lower trailing P/E, GSK or SYK?

GSK has the lower trailing P/E: GSK trades at 14.87 and SYK at 28.54. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GSK or SYK?

Over the past five years, SYK grew revenue faster — GSK at a 1.38% CAGR versus SYK at 9.72%.

Does GSK or SYK pay a bigger dividend?

GSK yields 3.86% and SYK yields 1.28% based on trailing dividends and the latest price.

How have GSK and SYK total returns compared?

Over the past 10 years, GSK delivered 5.71% and SYK delivered 10.20% annualized total return. Past performance doesn't predict future results.

GSK plc (GSK) vs Stryker Corporation (SYK)

A side-by-side comparison of GSK plc and Stryker Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

GSK

GSK plc

$94.22B

$47.03HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

SYK

Stryker Corporation

$105.59B

$275.43HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — GSK vs SYK

growth of $100 · dividends reinvested · last 10y

GSK +74.6% (+5.7%/yr)SYK +160.9% (+10.1%/yr)SYK compounded faster over this window

GSK SYK

GSK vs SYK: by the numbers

•SYK is the larger company ($105.59B vs $94.22B market cap).
•GSK trades at the lower trailing earnings multiple (14.87 vs 28.54 P/E), one valuation lens rather than an overall verdict.
•SYK grew revenue faster over the past five years (9.72% vs 1.38% CAGR).
•GSK pays the higher dividend yield (3.86% vs 1.28%).

Metrics side by side

Valuation

Metric	GSK	SYK
P/E ratio	14.87	28.54
Forward P/E	N/A	18.38
PEG ratio	N/A	1.92
P/S ratio	2.13	4.09
P/B ratio	4.05	4.40
EV / EBITDA	7.68	16.89
FCF yield	9.90%	4.45%

Profitability

Metric	GSK	SYK
Gross margin	72.71%	65.17%
Operating margin	20.72%	22.03%
Net margin	14.52%	14.43%
ROE	27.67%	15.55%
ROIC	13.95%	9.82%

Dividends

Metric	GSK	SYK
Dividend yield	3.86%	1.28%
Payout ratio	57.45%	36.48%

Growth (annualized)

Metric	GSK	SYK
Revenue CAGR (5Y)	1.38%	9.72%
EPS CAGR (5Y)	-0.71%	14.79%
FCF CAGR (5Y)	-2.45%	9.60%
Total return CAGR (5Y)	8.61%	1.59%

Frequently asked

Which has the lower trailing P/E, GSK or SYK?: GSK has the lower trailing P/E: GSK trades at 14.87 and SYK at 28.54. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GSK or SYK?: Over the past five years, SYK grew revenue faster — GSK at a 1.38% CAGR versus SYK at 9.72%.
Does GSK or SYK pay a bigger dividend?: GSK yields 3.86% and SYK yields 1.28% based on trailing dividends and the latest price.
How have GSK and SYK total returns compared?: Over the past 10 years, GSK delivered 5.71% and SYK delivered 10.20% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GSK analysis Full SYK analysis Interactive comparison tool

Dig into the metrics

GSK P/E ratio Stryker P/E ratio GSK dividend yield Stryker dividend yield GSK ROE Stryker ROE GSK operating margin Stryker operating margin GSK revenue growth Stryker revenue growth GSK free cash flow Stryker free cash flow

GSK & Stryker appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.